NEW YORK (GenomeWeb) – Sequenom said today that its second-half 2015 revenues will be lower than previously anticipated and has accordingly dropped its full-year revenue guidance to a range of 15 percent to 23 percent lower than its previous estimate of $150 million to $170 million.

The firm expects second-half 2015 revenues to be in the range of $57 million to $61 million and full-year revenues to be between $127 million and $131 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.